» Articles » PMID: 36873889

The Influencing Factors of Health-related Quality of Life of the General Population of Iran During the COVID-19 Pandemic

Overview
Specialty General Medicine
Date 2023 Mar 6
PMID 36873889
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 is a global challenge that negatively affects the health-related quality of life (HRQoL) of the general population. The current study aimed to evaluate HRQoL and its associated factors among the Iranian general population during the COVID-19 pandemic. The data were collected in 2021 using the EuroQol 5-Dimension 3-Level (EQ-5D-3L) and EQ-5D Visual Analog Scale (EQ VAS) questionnaires through an online survey. Participants were recruited social media from the Fars province. The multiple binary logistic regression model was used to identify factors influencing participants' HRQoL. Kolmogorov-Smirnov, the -test, ANOVA, and the chi-square test were used. All tests were conducted at a significance level of 5% using Stata 14.2 and SPSS 16. A total of 1,198 participants were involved in this cross-sectional study. The mean age of participants was 33.3 (SD:10.2), and more than half were women (55.6%). The mean EQ-5D-3L index value and EQ-VAS of the respondents were 0.80 and 77.53, respectively. The maximum scores of the EQ-5D-3L and EQ-VAS in the present study were 1 and 100, respectively. The most frequently reported problems were anxiety/depression (A/D) (53.7%), followed by pain/discomfort (P/D) (44.2%). Logistic regression models showed that the odds of reporting problems on the A/D dimension increased significantly with supplementary insurance, including concern about getting COVID-19, hypertension, and asthma, by 35% (OR = 1.35; = 0.03), 2% (OR = 1.02; = 0.02), 83% (OR = 1.83; = 0.02), and 6.52 times (OR = 6.52; = 0.01), respectively. The odds of having problems on the A/D dimension were significantly lower among male respondents, those in the housewives + students category, and employed individuals by 54% (OR = 0.46; = 0.04), 38% (OR = 0.62; = 0.02) and 41% (OR = 0.59; = 0.03), respectively. Moreover, the odds of reporting a problem on the P/D dimension decreased significantly in those belonging in a lower age group and with people who were not worried about getting COVID-19 by 71% (OR = 0.29; = 0.03) and 65% (OR = 0.35; = 0.01), respectively. The findings of this study could be helpful for policy-making and economic evaluations. A significant percentage of participants (53.7%) experienced psychological problems during the pandemic. Therefore, effective interventions to improve the quality of life of these vulnerable groups in society are essential.

Citing Articles

Quality-adjusted life expectancy norms for the Iranian population.

Mousavi A, Daroudi R, Alipour S, Akbari Sari A, Daastari F Popul Health Metr. 2025; 23(1):5.

PMID: 39948635 PMC: 11827415. DOI: 10.1186/s12963-025-00366-0.


Post-COVID-19 physical and cognitive impairments and associations with quality of life: a cross-sectional study.

Rahimi F, Saadat M, Hessam M, Ravanbakhsh M, Monjezi S Front Sports Act Living. 2024; 6:1246585.

PMID: 38504691 PMC: 10948450. DOI: 10.3389/fspor.2024.1246585.

References
1.
Algahtani F, Hassan S, Alsaif B, Zrieq R . Assessment of the Quality of Life during COVID-19 Pandemic: A Cross-Sectional Survey from the Kingdom of Saudi Arabia. Int J Environ Res Public Health. 2021; 18(3). PMC: 7863741. DOI: 10.3390/ijerph18030847. View

2.
Ping W, Zheng J, Niu X, Guo C, Zhang J, Yang H . Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic. PLoS One. 2020; 15(6):e0234850. PMC: 7302485. DOI: 10.1371/journal.pone.0234850. View

3.
Zare F, Ameri H, Madadizadeh F, Reza Aghaei M . Health-related quality of life and its associated factors in patients with type 2 diabetes mellitus. SAGE Open Med. 2021; 8:2050312120965314. PMC: 8107944. DOI: 10.1177/2050312120965314. View

4.
Scalone L, Cortesi P, Mantovani L, Ciampichini R, Cesana G . Reference Eq-5d-3l and Eq-5d-5l Data From the Italian General Population. Value Health. 2016; 17(7):A514-5. DOI: 10.1016/j.jval.2014.08.1591. View

5.
Taylor S, Landry C, Paluszek M, Fergus T, McKay D, Asmundson G . Development and initial validation of the COVID Stress Scales. J Anxiety Disord. 2020; 72:102232. PMC: 7198206. DOI: 10.1016/j.janxdis.2020.102232. View